Search Results 531-540 of 16090 for saffron dosage
The trial will be conducted in 2 parts: an initial Dose Escalation Phase (Part A) of CA-4948 in patients with Relapsed or Refractory Non-Hodgkin Lymphoma, (RR ...
Part 1 will identify the maximum tolerated dose(s) (MTD) of the combination regimen. Schedule A - GSK2110183 administered once daily with bortezomib (1.3 mg/m2) ...
... doses of these drugs are safe for people to take. We also want to learn ... The purpose of this study is to determine the maximum tolerated dose (MTD) of AG-270 ...
... dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also ...
Rochester, Minn. This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic ...
This phase Ib trial studies the side effects and best dose of a vaccine called H2NVAC before surgery in treating patients with HER2 expressing ductal carcinoma ...
ABBV-383 is an investigational drug being developed for the treatment of R/R Multiple Myeloma (MM). This study includes 2 parts; step-up dose optimization (Part ...
Please courtesy "Melanie Swift, M.D./COVID-19 Vaccine Allocation and Distribution/Mayo Clinic." She says the vaccines, which are administered in two doses ...
... dosages and risks/benefits. In the later phase (phase 3), researchers study ... May be receiving the following drugs (subjects on these therapies must be willing ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.